Alexander P. OttAssociateMcDermott Will & Emery Websitewww.mwe.comBlogwww.mwe.com/insightsConnectEmail202-756-8496 Professional Biography Alexander P. Ott is an associate in the law firm of McDermott Will & Emery LLP and is based in the Firm’s Washington, D.C., office. Alex focuses his practice on intellectual property litigation. More Legal and Business Bylines From Alexander P. Ott No En Banc Review of Panel Decision Vacating a Civil Contempt Remedy - (Posted On Monday, August 03, 2015) Only Basic Functions of a Processor Avoid Need for Disclosed Algorithm - EON Corp. IP Holdings LLC v. AT&T Mobility LLC - (Posted On Wednesday, July 01, 2015) PTO Refusal to Terminate Ongoing Proceeding Is Not Immediately Reviewable - (Posted On Sunday, May 31, 2015) Specific Application Will Not Avoid Ineligibility Unless Required by the Claims - (Posted On Thursday, April 30, 2015) Prior Art Must Criticize or Otherwise Disparage the Claimed Solution to Constitute a Teaching Away - (Posted On Monday, March 30, 2015) Would Have Been Obvious to Combine Prior Art that Mentions an Object with Standard Textbook that Describes that Object - (Posted On Sunday, March 01, 2015) Stays of Litigation Warranted Even When the CBM Review Does Not Address All Asserted Claims or All Invalidity Defenses - (Posted On Saturday, January 03, 2015) Covered Business Method (CBM) Patents: Claims Directed to a Mental Task Are Abstract, but Computerizing an Old Practice Is Not - (Posted On Monday, December 01, 2014) Injunction and Civil Contempt Remedy Vacated After PTO Cancels Claim in Reexamination - (Posted On Friday, August 29, 2014) Voluntary and Intentional Applicant Choices are Errors Under the Reissue Statute Only if They Arises from a False or Deficient Understanding of Fact or Law - (Posted On Thursday, July 31, 2014) Pagination Previous page ‹ Previous Page 6 Next page Next › Current Legal Analysis DOE Releases SAF Grand Challenge Roadmap Implementation Framework by: Lynn L. Bergeson , Carla N. Hutton California DFPI Poised to Fill Potential Regulatory Gap Amid Anticipated CFPB Leadership Shift by: A.J. S. Dhaliwal , Mehul N. Madia FDA Extends Comment Deadline for Proposed Post-Market Assessment Approach by: Food and Drug Law at Keller and Heckman Understanding French Export and Re-Export Prohibitions: Ministry of Armed Forces Releases FAQ on Non Re-Exportation Certificates by: Sabine Naugès , Michal Chajdukowski New CFPB Larger Participant Rule Boosts Oversight of Major Digital Payment Providers by: A.J. S. Dhaliwal , Mehul N. Madia California Poised to Fill Potential Regulatory Gap Amid Anticipated CFPB Leadership Shift by: A.J. S. Dhaliwal , Mehul N. Madia Upcoming Events Dec 10 2024 Legal AI Week 2024 Nov 25 2024 2024 Election: Impact on the Health Care Legal and Policy Landscape Webinar Dec 4 2024 TSCA 30/30 - December 4, 2024 Dec 4 2024 GLP-1 Drugs: What's Next after FDA's Resolution of Drug Shortages Dec 4 2024 REACH 30/30 - 04 December 2024 Dec 5 2024 Home Care Industry Update Dec 5 2024 Annual Review: Non-compete and Trade Secret Protection for Employers Dec 11 2024 2025 Annual Reporting & Proxy Season Update Print
